Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center
- 31 July 2005
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 52 (3), 255-259
- https://doi.org/10.1016/j.diagmicrobio.2005.02.015
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infectionsJournal of Antimicrobial Chemotherapy, 2004
- Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropeniaAnnals of Oncology, 2003
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- Treatment of Vancomycin-Resistant Enterococcal Infections in the Immunocompromised Host: Quinupristin-Dalfopristin in Combination with MinocyclineAntimicrobial Agents and Chemotherapy, 2001
- Antimicrobial-Drug ResistanceNew England Journal of Medicine, 1996
- Enterococcus faecium and Enterococcus faecalis Bacteremia: Acquisition and OutcomeClinical Infectious Diseases, 1995
- Management of Fever in Patients with Cancer and Treatment-Induced NeutropeniaNew England Journal of Medicine, 1993
- Increasing incidence of gram‐positive sepsis in cancer patientsMedical and Pediatric Oncology, 1978